| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 07/15/2009 | EP2078525A2 Treatment of tuberculosis using immunomodulator compounds |
| 07/15/2009 | EP2078086A1 Immunogenic affinity-conjugated antigen systems based on papaya mosaic virus and uses thereof |
| 07/15/2009 | EP2078082A1 Recombinant human interferon-like proteins |
| 07/15/2009 | EP2078074A2 Dosing regimen of activated protein c and variants having reduced anticoagulant activity |
| 07/15/2009 | EP2078029A2 Enantiomerically pure phosphoindoles as hiv inhibitors |
| 07/15/2009 | EP2077903A2 Process for the preparation of form i and form ii of ritonavir |
| 07/15/2009 | EP1866291B1 Antibacterial amide macrocycles vi |
| 07/15/2009 | EP1794172B1 Antiviral 4'-azido-nucleosides |
| 07/15/2009 | EP1773361B1 Probiotic bacteria based composition and use thereof in the prevention and/or treatment of respiratory pathologies and/or infections and in the improvement of the intestinal functionality |
| 07/15/2009 | EP1709005B1 High purity butoconazole nitrate with specified particle size and a process for preparation thereof |
| 07/15/2009 | EP1663287B1 Use of modified cyclosporins for the treatment of hcv disorders |
| 07/15/2009 | EP1653989B1 Anti-bacterial composition, especially for controlling gram-negative bacteria, comprising a peptide and an advantageously hydrophobic anti-bacterial agent |
| 07/15/2009 | EP1529037B1 Synthesis of 2-alkylcysteines, 2-(hydroxylated phenyl)-4-alkylthiazoline-4-carboxylic acids and derivatives thereof |
| 07/15/2009 | EP1299109B1 Bifunctional antibiotics |
| 07/15/2009 | EP1268802B1 Beta-like glycoprotein hormone polypeptide and heterodimer |
| 07/15/2009 | EP1179012B2 Long lasting fusion peptide inhibitors of viral infection |
| 07/15/2009 | EP1141015B1 Insulin-like growth factor (igf) i mutant variants |
| 07/15/2009 | CN101481356A Processes for the preparation of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile |
| 07/15/2009 | CN100513571C Recombinant helicobacter pylori catalase |
| 07/15/2009 | CN100513569C Recombinant helicobacter pylori heat shock protein 60 |
| 07/15/2009 | CN100513560C Method for virus propagation |
| 07/15/2009 | CN100513404C Novel compunds, pharmaceutical compositions containing same, and methods of use for same |
| 07/15/2009 | CN100512815C Matrine enteric coatel tablet and its preparation method |
| 07/15/2009 | CN100512811C Hepatoprotective activity of 10-o-p-hydroxybenzoyiaucubin |
| 07/15/2009 | CN100512798C Method for preparing submicron particle suspensions |
| 07/14/2009 | US7560569 (2S,4S)-1-[[(4-carbamoylbicyclo[2.2.2]oct-1-yl)amino]acetyl]-4-fluoropyrrolidine-2-carbonitrile, for treating type II diabetes; increase glucagon-like peptide activity |
| 07/14/2009 | US7560565 Method for preparing derivatives of 3-hydroxypicolinic acid |
| 07/14/2009 | US7560550 Method for the production of OH protected[4-(2.6-diamino-9H-purine-9-yl)-1.3-dioxolane-2-yl]methanol derivatives |
| 07/14/2009 | US7560548 antiinflammatory agent N-{[(2S)-4-(3,4-dichlorobenzyl)morpholin-2-yl]methyl}cyclopropane carboxamide; bronchitis, asthma, chronic obstructive pulmonary disease and rhinitis |
| 07/14/2009 | US7560527 Modified adenovirus fibre and uses |
| 07/14/2009 | US7560442 For prophylaxis and therapy of diabetes mellitus Type I and Type II, inflammation, cancer, necrosis, gastric ulcers, neurodegenerative diseases (Alzheimer's disease, Parkinson's disease), neuropathic diseases, neuropathic pain and polyneuropathy |
| 07/14/2009 | CA2429639C Stable azithromycin monohydrate |
| 07/14/2009 | CA2403321C Amide compounds and use thereof |
| 07/14/2009 | CA2390092C Solid dispersion pharmaceutical formulations |
| 07/14/2009 | CA2382302C A nucleic acid and encoding polypeptide for use in inhibiting tumor angiogenesis |
| 07/14/2009 | CA2306560C Topical antifungal composition |
| 07/14/2009 | CA2254548C Pharmaceutical compositions containing lactobacilli for treatment of vaginal infections |
| 07/10/2009 | CA2617691A1 Translocator component derivatives and uses thereof |
| 07/09/2009 | WO2009086438A2 2-methylene-(20s,25r)-19,26-dinor-vitamin d analogs |
| 07/09/2009 | WO2009086201A1 2-5a analogs and their use as anti-cancer, anti-viral and anti- paras iti c agents |
| 07/09/2009 | WO2009086192A1 Biodegradable phosphate protected nucleotide derivatives and their use as cancer, anti viral and anti parasitic agents |
| 07/09/2009 | WO2009086139A1 Condensed pentacyclic derivatives for use in the treatment of flaviviridae infections |
| 07/09/2009 | WO2009085659A1 Crystalline forms of n-(tert-butoxycarbonyl)-3-methyl-l-valyl-(4r)-4-((7-chloro-4-methoxy-1-isoquinolinyl)oxy)-n-((1r,2s)-1-((cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)-l-prolinamide |
| 07/09/2009 | WO2009085651A1 Metal carbonate particles for use in medicine and methods of making thereof |
| 07/09/2009 | WO2009085256A1 Anti-hiv compounds |
| 07/09/2009 | WO2009085096A2 Non-leaching, non-fouling antimicrobial coatings |
| 07/09/2009 | WO2009084975A1 Composition exhibiting high osmotic antimicrobial, anti-inflammatory and regeneration activity |
| 07/09/2009 | WO2009084974A1 1,3-dialkyl-benzimidazole halogenides exhibiting regeneration, anti-inflammatory and antimicrobial activity |
| 07/09/2009 | WO2009084732A1 Agent for alleviating adverse side effects produced in interferon/ribavirin combination therapy |
| 07/09/2009 | WO2009084621A1 Pyridine derivative substituted with heterocycle and phosphonoxymethyl group and antifungal agent containing the same |
| 07/09/2009 | WO2009084614A1 Imidazole carbonyl compound |
| 07/09/2009 | WO2009084494A1 Antimicrobial agent for gram-positive bacteria |
| 07/09/2009 | WO2009083755A1 Use of t cells expressing cd16 receptors for enhancing the antibody-dependent cellular cytotoxiciy (adcc) |
| 07/09/2009 | WO2009083663A2 Cyclic peptides comprising at least one aza-β3-aminoacyl residue and uses thereof |
| 07/09/2009 | WO2009083521A2 Antibacterial compositions comprising an antiseptic in combination with an antibiotic |
| 07/09/2009 | WO2009083520A2 Liquid oral florfenicol compositions which can be diluted in drinking water |
| 07/09/2009 | WO2009082819A1 Novel lupane derivatives |
| 07/09/2009 | WO2009082818A1 Novel c-21-keto lupane derivatives preparation and use thereof |
| 07/09/2009 | WO2009082792A1 Antimicrobial composition comprising an extract of a polyporaceae and a process for making the same. |
| 07/09/2009 | WO2009067225A3 Boceprevir derivatives for the treatment of hcv infections |
| 07/09/2009 | WO2009046369A3 Use of a specific dosage regimen of ifn-alpha and ribavirin for treating hepatitis c |
| 07/09/2009 | WO2009043524A3 Use of a peptide as therapeutic agent |
| 07/09/2009 | WO2009033814A3 Use of the peptide combination thymosin beta 4 and delta sleep inducing peptide as a therapeutic agent |
| 07/09/2009 | WO2009033806A3 Use of gly-pro-glu-oh (gpe) as a therapeutic agent |
| 07/09/2009 | WO2009033764A3 Use of a peptide as a therapeutic agent |
| 07/09/2009 | WO2009033749A3 Use of thymopentin as a therapeutic agent |
| 07/09/2009 | WO2009033748A3 Use of osteostatin, alone or in combination with thymopentin, as a therapeutic agent |
| 07/09/2009 | WO2009023355A3 Compositions and methods for reducing the toxicity of certain toxins |
| 07/09/2009 | WO2009022185A3 6, 6-fused heterocycles, their pharmaceutical compositions and methos of use |
| 07/09/2009 | WO2008132134A9 Novel antibody molecules and nucleic acids binding to fungal stress protein hsp90 |
| 07/09/2009 | WO2008130368A3 Transcription factor modulating compounds and methods of use thereof |
| 07/09/2009 | WO2008034388A8 Virus-like particles of capsid proteins from human papillomavirus type 16/58/18/6/11 and the method for preparation and the uses thereof |
| 07/09/2009 | US20090176969 Cloning genes from streptomyces cyaneogriseus subsp. noncyanogenus for biosynthesis of antibiotics and methods of use |
| 07/09/2009 | US20090176887 Biocidal Compositions and Methods |
| 07/09/2009 | US20090176886 Polymorphic Forms of Oseltamivir Phosphate |
| 07/09/2009 | US20090176869 Halogenated Rhodamine Derivatives and Applications Thereof |
| 07/09/2009 | US20090176858 Hcv protease inhibitors and uses thereof |
| 07/09/2009 | US20090176842 Substituted arylsulfonamides as antiviral agents |
| 07/09/2009 | US20090176824 7- (4-substituted-3-cyclopropylaminomethyl-1-pyrrolidinyl) quinolonecarboxylic acid derivative technical field |
| 07/09/2009 | US20090176821 Amide and Carbamate Derivatives of Alkyl Substituted N-[4-(4-Amino-1H-Imidazo[4,5-C] Quinolin-1-YL)Butyl]Methanesulfonamides and Methods |
| 07/09/2009 | US20090176813 Aqueous suspensions of tmc278 |
| 07/09/2009 | US20090176806 protein kinase C or glycogen synthase kinase-3-beta inhibitors such as 3-(2-chlorophenyl)-4-[1-(3-hydroxypropyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]-1H-pyrrole-2,5-dione, used for treating cardiovascular, skin, nervous system disorders and immunological disorders, diabetes, inflammatory diseases and cancer |
| 07/09/2009 | US20090176799 Phosphodiesterase 4 inhibitors |
| 07/09/2009 | US20090176778 Certain nitrogen containing bicyclic chemical entities for treating viral infections |
| 07/09/2009 | US20090176776 Small molecule inhibitors of hiv-1 capsid assembly |
| 07/09/2009 | US20090176773 Non-Peptidic Inhibitors of AKAP/PKA Interaction |
| 07/09/2009 | US20090176771 Gyrase inhibitors and uses thereof |
| 07/09/2009 | US20090176766 Imidazolidinone and imidazolidinethione derivatives |
| 07/09/2009 | US20090176743 Methods for treating or preventing reactivation of a latent herpesvirus infection |
| 07/09/2009 | US20090176730 N4-acylcytosine nucleosides for treatment of viral infections |
| 07/09/2009 | US20090176721 Nucleoside analogs with carboxamidine modified monocyclic base |
| 07/09/2009 | US20090176720 Compositions containing piperacillin and tazobactam useful for injection |
| 07/09/2009 | US20090176716 Inhibitors of cancer cell, t-cell and keratinocyte proliferation |
| 07/09/2009 | US20090176707 Human signal peptide-containing proteins |
| 07/09/2009 | US20090176703 Neuropeptides for aquatic organisms culture |
| 07/09/2009 | US20090176206 Toll-like receptor 2 (tlr-2) haplotypes predict outcome of patients |
| 07/09/2009 | US20090175971 Method of using composition comprising pomegranate extracts against the common cold |
| 07/09/2009 | US20090175963 Antiviral composition comprising lycoris squamigera extracts |
| 07/09/2009 | US20090175952 Cefuroxime axetil granule and process for the preparation thereof |
| 07/09/2009 | US20090175951 Nanoparticulate compositions of immunosuppressive agents |